56
https://pubmed.ncbi.nlm.nih.gov/38095251
The abstract describes updates in the treatment of ulcerative colitis, including the use of 5-ASA, corticosteroids, and biologics to achieve clinical, endoscopic, and histological remission and improve quality of life.